To Evaluate the Efficacy and Safety of SG301 SC Injection in Systemic Lupus Erythematosus
Clinical trial NCT07447986 · RECRUITING
Trial details
- NCT number
- NCT07447986
- Sponsor
- Hangzhou Sumgen Biotech Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-26
- Primary completion
- 2027-09-30
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.